Cargando…
The Challenges and Opportunities of Translational Pathology
Translational pathology has not caught up with the quality and quantity of translational medicine. Thus, challenges and opportunities related to translational pathology are discussed here. Pathologists should actively participate in reverse translational research that seeks mechanistic insights to e...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302533/ https://www.ncbi.nlm.nih.gov/pubmed/35874625 http://dx.doi.org/10.14218/jctp.2022.00001 |
_version_ | 1784751652033527808 |
---|---|
author | Zhang, Lanjing |
author_facet | Zhang, Lanjing |
author_sort | Zhang, Lanjing |
collection | PubMed |
description | Translational pathology has not caught up with the quality and quantity of translational medicine. Thus, challenges and opportunities related to translational pathology are discussed here. Pathologists should actively participate in reverse translational research that seeks mechanistic insights to explain clinical findings and/or solve clinical problems. Challenges in translational pathology include ambiguity in defining translational pathology, pathologists’ mindsets about translational research, lack of sufficient workforce and immature publication outlets. However, with collective wisdom and support of various stakeholders, we can expand the pool of pathologist scientists, build a translational pathology community and drive innovations in medicine through computational, molecular genetic/genomic and digital pathology approaches. |
format | Online Article Text |
id | pubmed-9302533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-93025332022-07-21 The Challenges and Opportunities of Translational Pathology Zhang, Lanjing J Clin Transl Pathol Article Translational pathology has not caught up with the quality and quantity of translational medicine. Thus, challenges and opportunities related to translational pathology are discussed here. Pathologists should actively participate in reverse translational research that seeks mechanistic insights to explain clinical findings and/or solve clinical problems. Challenges in translational pathology include ambiguity in defining translational pathology, pathologists’ mindsets about translational research, lack of sufficient workforce and immature publication outlets. However, with collective wisdom and support of various stakeholders, we can expand the pool of pathologist scientists, build a translational pathology community and drive innovations in medicine through computational, molecular genetic/genomic and digital pathology approaches. 2022-06 2022-02-23 /pmc/articles/PMC9302533/ /pubmed/35874625 http://dx.doi.org/10.14218/jctp.2022.00001 Text en https://creativecommons.org/licenses/by-nc/4.0/This article has been published under the terms of Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), which permits noncommercial unrestricted use, distribution, and reproduction in any medium, provided that the following statement is provided. |
spellingShingle | Article Zhang, Lanjing The Challenges and Opportunities of Translational Pathology |
title | The Challenges and Opportunities of Translational Pathology |
title_full | The Challenges and Opportunities of Translational Pathology |
title_fullStr | The Challenges and Opportunities of Translational Pathology |
title_full_unstemmed | The Challenges and Opportunities of Translational Pathology |
title_short | The Challenges and Opportunities of Translational Pathology |
title_sort | challenges and opportunities of translational pathology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302533/ https://www.ncbi.nlm.nih.gov/pubmed/35874625 http://dx.doi.org/10.14218/jctp.2022.00001 |
work_keys_str_mv | AT zhanglanjing thechallengesandopportunitiesoftranslationalpathology AT zhanglanjing challengesandopportunitiesoftranslationalpathology |